The New Year's Champagne turned flat for Madrigal Pharmaceuticals (NASDAQ: MDGL) on Tuesday. Investors traded out of the ...

BofA analyst Alec Stranahan raised the firm’s price target on Krystal Biotech (KRYS) to $272 from $255 and keeps a Buy rating on the shares. The ...

O4, Jared Holz of Mizuho joined ‘Power Lunch’ on CNBC to talk about how to play biotech moving into 2026. Holz noted that ...

The volatile biotech industry has done reasonably well so far in 2025 amid the ongoing tariff saga. Most pharma/biotech bigwigs are now investing heavily in manufacturing plants/operations in the ...

A big premium paid to acquire Avidity Biosciences is bolstering the merger case for Dyne Therapeutics, analyst says Dyne Therapeutics' stock sees record rally, but one analyst says it could still ...

Abivax SA soared about 1,300% after successful trial results for a bowel disease drug, Argenx SE was added to the elite Euro Stoxx 50 Index and smaller names including Valneva SE and Inventiva also ...

Recursion Pharmaceuticals is applying artificial intelligence to the drug discovery process. Recursion has several cancer therapy candidates in early-stage clinical trials. Drug trials often fail. The ...

Biotech stocks are emerging from a four-year slump. The SPDR S&P Biotech exchange-traded fund XBI, a proxy for the sector, is up 25% so far this year through Oct. 31, beating the S&P 500 SPX by 9 ...

C4 Therapeutics Inc. (NASDAQ: CCCC) is one of the best biotech penny stocks to buy according to analysts. On December 17, ...

Vivo Biotech Share: compare Vivo Biotech with up to two competing stocks only on Moneycontrol. Use our stock comparison tool to check price, market cap, returns & more ...

Shares of Ironwood Pharmaceuticals shot up about 30% as of 1:30 p.m. on Friday hours after the company said it has lowered ...